Search results
Showing 136 to 150 of 565 results for pregnancy
effectiveness of corticosteroids for women with severe nausea and vomiting in pregnancy? Any explanatory notes(if applicable) For a...
in helping women with diabetes to achieve blood glucose targets before pregnancy? Any explanatory notes(if applicable) Babies born to...
This guideline covers managing and monitoring diabetic retinopathy in people under the care of hospital eye services. This includes non-proliferative and proliferative diabetic retinopathy, and diabetic macular oedema.
This quality standard covers the recognition, diagnosis and early management of suspected sepsis in people over 16 who are not or have not recently been pregnant. It describes high-quality care in priority areas for improvement.
View quality statements for QS213Show all sections
Sections for QS213
- Quality statements
- Quality statement 1: Assessment in acute settings
- Quality statement 2: Assessment outside acute settings
- Quality statement 3: Urgent assessment and antibiotic treatment for people at high risk
- Quality statement 4: Intravenous fluids
- Quality statement 5: Escalation of care
- Quality statement 6: Information for people whose condition is managed outside acute hospital settings
- Update information
Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease (TA20)
Evidence-based recommendations on the use of riluzole (Rilutek) for treating motor neurone disease (MND).
The complete list of all our published indicators, for measuring outcomes that reflect the quality of care or processes, linked by evidence to improved outcomes.
care for them, about the use of nicotine-containing e‑cigarettes during pregnancy? Any explanatory notes(if applicable) For a short...
NICE has developed a medtech innovation briefing (MIB) on Natural Cycles for monitoring fertility .
We are listening to your views on this Technology appraisal guidance. Comments close 5 December 2025.
We are listening to your views on this Technology appraisal guidance. Comments close 17 December 2025.
This guideline covers assessment of people aged 16 and over with symptoms and signs of acute respiratory infection (bacterial or viral) at first remote or in-person contact with NHS services. It also covers the initial management of any infections. It aims to support healthcare practitioners in making sure that people’s treatment follows the best care pathway. It forms part of a suite of work on virtual wards being undertaken by NICE.
We are listening to your views on this Technology appraisal guidance. Comments close 3 December 2025.
Lumella point-of-care test for assessing pre-eclampsia risk (MIB287)
NICE has developed a medtech innovation briefing (MIB) on Lumella point-of-care test for assessing pre-eclampsia risk .
is no good evidence that aspirin causes harm to the baby in early pregnancy when taken at lower doses, or at higher doses taken short...
This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines.